西地那非:从心绞痛到SARS-CoV-2

IF 1.2 Q3 Medicine
G.M. Khairy, S.M.A. El-Sheikh, N.Z. Eleiwa, A.A.A. Galal
{"title":"西地那非:从心绞痛到SARS-CoV-2","authors":"G.M. Khairy,&nbsp;S.M.A. El-Sheikh,&nbsp;N.Z. Eleiwa,&nbsp;A.A.A. Galal","doi":"10.1016/j.sexol.2021.05.002","DOIUrl":null,"url":null,"abstract":"<div><p>Sildenafil was first examined as an alternative to nitrates for the management of angina pectoris and hypertension and eventually developed into an oral therapeutic agent used for the treatment of erectile dysfunction. There are appropriate indicators that PDE5 inhibitors may also modify the detrimental consequences of the immune system over-stimulation, supplying a new chance for their use in SARS-CoV2 patients. The use of sildenafil for the management of SARS-CoV2 has been suggested based on its several mechanisms of action and therapeutic effects and on the clinical features of SARS-CoV2 which similar to those of other pathologies treated with the PDE5 inhibitors. Here we review fundamental highlights in the enhancement of sildenafil for numerous scientific disorders and consider practicable new uses for this versatile drug.</p></div>","PeriodicalId":45416,"journal":{"name":"Sexologies","volume":"30 4","pages":"Pages e149-e154"},"PeriodicalIF":1.2000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.sexol.2021.05.002","citationCount":"0","resultStr":"{\"title\":\"Sildenafil: From angina to SARS-CoV-2\",\"authors\":\"G.M. Khairy,&nbsp;S.M.A. El-Sheikh,&nbsp;N.Z. Eleiwa,&nbsp;A.A.A. Galal\",\"doi\":\"10.1016/j.sexol.2021.05.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Sildenafil was first examined as an alternative to nitrates for the management of angina pectoris and hypertension and eventually developed into an oral therapeutic agent used for the treatment of erectile dysfunction. There are appropriate indicators that PDE5 inhibitors may also modify the detrimental consequences of the immune system over-stimulation, supplying a new chance for their use in SARS-CoV2 patients. The use of sildenafil for the management of SARS-CoV2 has been suggested based on its several mechanisms of action and therapeutic effects and on the clinical features of SARS-CoV2 which similar to those of other pathologies treated with the PDE5 inhibitors. Here we review fundamental highlights in the enhancement of sildenafil for numerous scientific disorders and consider practicable new uses for this versatile drug.</p></div>\",\"PeriodicalId\":45416,\"journal\":{\"name\":\"Sexologies\",\"volume\":\"30 4\",\"pages\":\"Pages e149-e154\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2021-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.sexol.2021.05.002\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sexologies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1158136021000475\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexologies","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1158136021000475","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

西地那非最初作为硝酸盐的替代品用于治疗心绞痛和高血压,并最终发展成为一种用于治疗勃起功能障碍的口服治疗剂。有适当的指标表明,PDE5抑制剂也可能改变免疫系统过度刺激的有害后果,为其在SARS-CoV2患者中的应用提供了新的机会。基于其多种作用机制和治疗效果,以及对SARS-CoV2的临床特征(与PDE5抑制剂治疗的其他病理相似),建议使用西地那非治疗SARS-CoV2。在这里,我们回顾了西地那非在许多科学疾病中增强的基本亮点,并考虑了这种多功能药物的实际新用途。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Sildenafil: From angina to SARS-CoV-2

Sildenafil was first examined as an alternative to nitrates for the management of angina pectoris and hypertension and eventually developed into an oral therapeutic agent used for the treatment of erectile dysfunction. There are appropriate indicators that PDE5 inhibitors may also modify the detrimental consequences of the immune system over-stimulation, supplying a new chance for their use in SARS-CoV2 patients. The use of sildenafil for the management of SARS-CoV2 has been suggested based on its several mechanisms of action and therapeutic effects and on the clinical features of SARS-CoV2 which similar to those of other pathologies treated with the PDE5 inhibitors. Here we review fundamental highlights in the enhancement of sildenafil for numerous scientific disorders and consider practicable new uses for this versatile drug.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Sexologies
Sexologies PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
1.80
自引率
16.70%
发文量
48
期刊介绍: Sexologies offers a large panel of information to all health professionals working in the field of sexuality: anatomophysiological and basic research; psychodynamic, cognitive, behavioural and relational evaluations of sexual difficulties; epidemiological, sociological, forensic data; information on new sexoactive molecules; research on sexual physiology, reports on specialized congresses; press and books reviews; ethical aspects; calendar of major events of sexology around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信